Vision and mission statement of Single Use Support GmbH

It is and always has been one of humankind’s biggest endeavors to prolong life by staying healthy; to improve quality of life, reduce child mortality and the number of terminal illnesses.
After many years of working in this industry with its unbelievable options we started discovering weak points in the manufacturing and logistics processes.

On a regular basis, entire shipments of vital and high-quality substances become useless due to faulty containers, contamination, disruptions of the cold chain, or simply because of inappropriate handling.

It became ever more frustrating for us to take this for granted. On the other hand we knew that it would be a massive challenge to devise and implement an entire process for a globally organized industry, to make it ready for market and to protect our innovations by taking out patents – in short: To contribute our part in the quest for prolonging life.

We knew that we would only be able to achieve this if every single link in the new process chain would constitute an innovation in itself; together, these innovations would then create a real “game changer” that would be impossible to ignore even by this powerful industry – because it builds upon existing and established technology, increases efficiency and reduces costs thanks to minimizing losses towards 0%.

Our mission:

“We founded our company to increase patient safety by optimizing single-use technology in biopharma at the highest technological level.”

Yes, it is possible.

Through intense research and collaboration with this great industry and thanks to a highly motivated team we were able to increase the industry’s quality standards as well as patient safety dramatically and traceably in an extremely short timeframe.

Our vision:

“We are creating a globally active company that is a technology leader in the field of liquid logistics for pharmaceutical applications, pushing the quality of life and human health to an ever-higher level worldwide.”

Thanks to an increasing collaboration with the biopharma industry and institutions like the FDA every day brings us closer to reaching our vision.